person · Reporting owner
Schaeffer Orlov S Nicole
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSMED IncINSM · Entity 3174 | Chief People Strategy Officer | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSMED Inc
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,754 |
Ending reported balance
After 2026-01-02 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2026-01-02 · Grant · Acquired 5,293 · Balance 41,754 F1: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2: Each RSU was granted on January 2, 2026 for no consideration. Row 2 · 2026-01-02 · Exercise / conversion · Acquired 87,290 · Balance 129,044 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Row 3 · 2026-01-02 · Sale · Disposed 31,030 · Balance 98,014 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4: This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 4 · 2026-01-02 · Sale · Disposed 34,103 · Balance 63,911 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5: This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 5 · 2026-01-02 · Sale · Disposed 12,832 · Balance 51,079 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6: This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 6 · 2026-01-02 · Sale · Disposed 9,125 · Balance 41,954 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7: This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 7 · 2026-01-02 · Sale · Disposed 200 · Balance 41,754 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8: This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $177.12 · Expires 2036-01-02 | Direct | 27,600 |
Reported balance
After 2026-01-02 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-01-02 · Grant · Acquired 27,600 · Balance 27,600 F9: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.91 · Expires 2029-01-03 | Direct | 0 |
Reported balance
After 2026-01-02 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-01-02 · Exercise / conversion · Disposed 87,290 · Balance 0 F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F10: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
F2: Each RSU was granted on January 2, 2026 for no consideration.
F3: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F4: This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F6: This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F7: This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F8: This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F9: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.
F10: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 27,370 | $0.00 Strike: $65.72 | $0.00 |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · derivative · entry 6 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,370 Underlying: Common Stock · 27,370 shares Expires 2035-01-08 F7 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 5,706 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,012 F4 · shares: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F5 · price: Each RSU was granted on January 8, 2025 for no consideration. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:45 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,209 | $65.84 | $79,600.56 |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,306 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 23:45 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 2,596 | $65.88 | $171,024.48 |
DisclosureSEC source: 0001628280-25-001205 · wk-form4_1736552710.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,515 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,596 shares sold at prices ranging from $65.72 to $65.96 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F3 · balance_after: Includes 11 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| September 10, 2024 Filed Sep 10, 2024 23:49 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 37,575 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-24-040063 · wk-form4_1726012171.xml · derivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,575 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| September 10, 2024 Filed Sep 10, 2024 23:49 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 9,582 | $71.88 | $688,754.16 |
DisclosureSEC source: 0001628280-24-040063 · wk-form4_1726012171.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,100 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 9,582 shares sold at prices ranging from $71.80 to $72.06 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 10, 2024 Filed Sep 10, 2024 23:49 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 27,993 | $71.37 | $1,997,860.41 |
DisclosureSEC source: 0001628280-24-040063 · wk-form4_1726012171.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,682 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 27,993 shares sold at prices ranging from $70.79 to $71.79 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 10, 2024 Filed Sep 10, 2024 23:49 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 37,575 | $10.85 | $407,688.75 |
DisclosureSEC source: 0001628280-24-040063 · wk-form4_1726012171.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 12, 2024 Filed Aug 14, 2024 20:26 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 9,469 | $72.49 | $686,407.81 |
DisclosureSEC source: 0001628280-24-037223 · wk-form4_1723667167.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,100 F1 · price: This is the weighted average sales price representing 9,469 shares sold at prices ranging from $72.36 to $72.63 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. F2 · balance_after: Includes 809 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:23 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 41,250 | $0.00 Strike: $22.76 | $0.00 |
DisclosureSEC source: 0001628280-24-026851 · wk-form4_1717618996.xml · derivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,250 shares Expires 2025-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:23 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 13,750 | $0.00 Strike: $16.07 | $0.00 |
DisclosureSEC source: 0001628280-24-026851 · wk-form4_1717618996.xml · derivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,750 shares Expires 2025-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:23 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 55,000 | $55.33 | $3,043,150.00 |
DisclosureSEC source: 0001628280-24-026851 · wk-form4_1717618996.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,760 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 55,000 shares sold at prices ranging from $54.69 to $55.65 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:23 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 41,250 | $22.76 | $938,850.00 |
DisclosureSEC source: 0001628280-24-026851 · wk-form4_1717618996.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 163,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 20:23 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 13,750 | $16.07 | $220,962.50 |
DisclosureSEC source: 0001628280-24-026851 · wk-form4_1717618996.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:44 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 27,500 | $0.00 Strike: $12.58 | $0.00 |
DisclosureSEC source: 0001628280-24-025893 · wk-form4_1717105441.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,500 shares Expires 2024-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:44 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 27,500 | $49.53 | $1,362,075.00 |
DisclosureSEC source: 0001628280-24-025893 · wk-form4_1717105441.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,760 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:44 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 27,500 | $12.58 | $345,950.00 |
DisclosureSEC source: 0001628280-24-025893 · wk-form4_1717105441.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:36 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 6,508 | $25.53 | $166,149.24 |
DisclosureSEC source: 0001628280-24-023605 · wk-form4_1715805404.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,760 F4 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. F5 · price: This is the weighted average sales price representing 6,508 shares sold at prices ranging from $25.50 to $25.55 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:36 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 65,230 | $0.00 Strike: $25.83 | $0.00 |
DisclosureSEC source: 0001628280-24-023605 · wk-form4_1715805404.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,230 Underlying: Common Stock · 65,230 shares Expires 2034-05-13 F6 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:36 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 13,308 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-023605 · wk-form4_1715805404.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,268 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on May 13, 2024 for no consideration. F3 · balance_after: Due to a clerical error related to the reporting of shares previously withheld by the Company to satisfy tax obligations upon the vesting of RSUs, this number was previously overstated by 24 shares. This value reflects the adjustment, decreasing the amount beneficially owned by 24 shares. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 21:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 503 | $0.00 Strike: $20.49 | $0.00 |
DisclosureSEC source: 0001628280-24-001164 · wk-form4_1705007402.xml · derivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 503 shares Expires 2024-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 21:10 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 3,165 | $28.74 | $90,962.10 |
DisclosureSEC source: 0001628280-24-001164 · wk-form4_1705007402.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,984 F2 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F3 · price: This is the weighted average sales price representing 3,165 shares sold at prices ranging from $28.72 to $28.74 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 21:10 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 503 | $29.56 | $14,868.68 |
DisclosureSEC source: 0001628280-24-001164 · wk-form4_1705007402.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,149 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 21:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 503 | $20.49 | $10,306.47 |
DisclosureSEC source: 0001628280-24-001164 · wk-form4_1705007402.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 05, 2024 Filed Jan 5, 2024 22:32 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,457 | $29.28 | $42,660.96 |
DisclosureSEC source: 0001628280-24-000696 · wk-form4_1704493919.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,149 F4 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 22:32 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 58,260 | $0.00 Strike: $29.13 | $0.00 |
DisclosureSEC source: 0001628280-24-000696 · wk-form4_1704493919.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,260 Underlying: Common Stock · 58,260 shares Expires 2034-01-04 F5 · derivative.exercise_date: Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 22:32 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 11,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-000696 · wk-form4_1704493919.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,606 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration. F3 · balance_after: Includes 257 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| December 28, 2023 Filed Jan 2, 2024 21:04 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 22,288 | $0.00 Strike: $20.49 | $0.00 |
DisclosureSEC source: 0001628280-24-000052 · wk-form4_1704229471.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 503 Underlying: Common Stock · 22,288 shares Expires 2024-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| December 28, 2023 Filed Jan 2, 2024 21:04 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 22,288 | $32.00 | $713,216.00 |
DisclosureSEC source: 0001628280-24-000052 · wk-form4_1704229471.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,549 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 28, 2023 Filed Jan 2, 2024 21:04 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 22,288 | $20.49 | $456,681.12 |
DisclosureSEC source: 0001628280-24-000052 · wk-form4_1704229471.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 1,024 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| May 17, 2023 Filed May 17, 2023 20:13 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,972 | $18.16 | $35,811.52 |
DisclosureSEC source: 0001628280-23-018691 · wf-form4_168435436955097.xml · nonDerivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,525 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:13 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,217 | $18.45 | $22,453.65 |
DisclosureSEC source: 0001628280-23-018691 · wf-form4_168435436955097.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,497 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:13 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,830 | $19.22 | $35,172.60 |
DisclosureSEC source: 0001628280-23-018691 · wf-form4_168435436955097.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,714 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:13 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 121,850 | $0.00 Strike: $18.95 | $0.00 |
DisclosureSEC source: 0001628280-23-018174 · wf-form4_168418156777258.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,850 Underlying: Common Stock · 121,850 shares Expires 2033-05-11 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:13 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 26,385 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-018174 · wf-form4_168418156777258.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,544 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2023, for no consideration. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:11 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 2,435 | $17.95 | $43,708.25 |
DisclosureSEC source: 0001628280-23-000961 · wf-form4_167355789878115.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,159 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · price: This is the weighted average sales price representing 2,435 shares sold at prices ranging from $17.93 to $17.96 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:27 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 29,050 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001401017-23-000001 · wf-form4_167304043493381.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,050 Underlying: Common Stock · 29,050 shares Expires 2033-01-05 F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:27 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 6,332 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001401017-23-000001 · wf-form4_167304043493381.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,594 F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant. F4 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:27 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,448 | $19.73 | $28,569.04 |
DisclosureSEC source: 0001401017-23-000001 · wf-form4_167304043493381.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,262 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · balance_after: Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| May 17, 2022 Filed May 18, 2022 20:07 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,670 | $20.27 | $33,850.90 |
DisclosureSEC source: 0001140361-22-019780 · form4.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,822 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:07 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,114 | $18.41 | $20,508.74 |
DisclosureSEC source: 0001140361-22-019780 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,492 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. Read SEC document |
| May 11, 2022 Filed May 13, 2022 22:12 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 69,060 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001140361-22-019174 · form4.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,060 Underlying: Common Stock · 69,060 shares Expires 2032-05-11 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| May 11, 2022 Filed May 13, 2022 22:12 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 14,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-019174 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,606 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on May 11, 2022, for no consideration. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 21:41 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 925 | $25.11 | $23,226.75 |
DisclosureSEC source: 0001140361-22-001605 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,961 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 21:19 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,612 | $26.00 | $41,912.00 |
DisclosureSEC source: 0001140361-22-000956 · form4.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,428 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:06 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 45,700 | $0.00 Strike: $26.43 | $0.00 |
DisclosureSEC source: 0001140361-22-001168 · form4.xml · derivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,700 Underlying: Common Stock · 45,700 shares Expires 2032-01-06 F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:06 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 9,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-001168 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,886 F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant. F2 · price: Each Restricted Stock Unit was received as a grant on January 6, 2022, for no consideration. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 21:19 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,503 | $27.61 | $41,497.83 |
DisclosureSEC source: 0001140361-22-000956 · form4.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,040 F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees. F2 · balance_after: Includes 29 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:27 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001140361-21-036424 · form4.xml · derivative · entry 5 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options vested and became exercisable with respect to 12,500 shares upon receipt of the first written acceptance of an NDA or MAA filing from an applicable regulatory authority (FDA or EMA); and with respect to the remaining 12,500 shares upon receipt of the first written approval of an NDA or MAA filing from an applicable regulatory authority (FDA or EMA). Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:27 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001140361-21-036424 · form4.xml · derivative · entry 4 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 36,000 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.